Changes and significance of serum plasminogen activator inhibitor-1 and nuclea factor erythroid-2-related factor2 in patients of type 2 diabetic kidney disease

Wang He; Xin Huanhuan; Tian Xi

doi:10.3969/j.issn.1674-3245.2022.04.016

Home>Articles>Changes and significance of serum plasminogen activator inhibitor-1 and nuclea factor erythroid-2-related factor2 in patients of type 2 diabetic kidney disease

DOI: 10.3969/j.issn.1674-3245.2022.04.016

Changes and significance of serum plasminogen activator inhibitor-1 and nuclea factor erythroid-2-related factor2 in patients of type 2 diabetic kidney disease

Wang He

Xin Huanhuan

Tian Xi

Machine-generated Keywords：

Publication Date：2022-08-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 311-314 )

Chinese Journal of Health Care and Medicine

ISTIC

ISSN：1674-3245

Year, Vol.(Issue)：2022,24(4)